Newsletter registration

Используя наш сайт, Вы соглашаетесь с тем, что в целях обеспечения оптимального сервиса на Вашем компьютере будут сохраняться файлы Cookie и будет использоваться служба Google Analytics. Более подробную информацию об этом Вы найдетездесь.
Австрия
Блестящие перспективы для роста Вашей прибыли

Growth in Austria’s life sciences sector

The number of life sciences companies has climbed to 823 since 2012, comprising an increase of fourteen percent. Revenue has grown by almost eight percent or EUR 1.4 billion in this period, and the number of employees has risen by three percent or a total of 1,500. More than two-thirds of the people employed by biotech and pharmaceutical companies are involved in research and development. On balance, life sciences companies in Austria invested EUR 917 million last year.

In 2014 almost 20,000 employees were working at 55 research institutions (17 research facilities, thirteen universities of applied sciences and 25 non-university research institutes) focusing on the field of life sciences. More than half of them, or a total of 11,229, are involved in research. They have a budget of EUR 1.44 billion at their disposal, of which EUR 366 million represent third-party funding. There were close to 60,000 students and almost 8,000 graduates in the field of life sciences in Austria last year.   

Service: www.lifescienceaustria.at

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Австрия занимает ключевую позицию для бизнеса между Востоком и Западом. Мы высоко ценим превосходную инфраструктуру, в особенной мере отличное воздушное сообщение, высококвалифицированные трудовые кадры, а также первоклассное качество жизни в Вене.

ЛУКОЙЛ

Lukoil Logo
Все отзывы

Новости Австрии, как площадки для бизнеса

In May Austria is THE startup hotspot

In their role as speakers, Apple co-founder Steve Wozniak, Angie Jones of Twitter and Microsoft AI expert Joseph Sirosh inspired an audience of 8,000 people attending the WeAreDevelopers Conference in Vienna in the middle of May.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости